BeStock  

Absci Corp ABSI

US equityMarket cap rank #2985AI medical concept stocks
$7.51 −$0.65 (-7.97%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $7.61 +1.33%
Open$7.91
Prev close$8.16
Day range$7.44 – $8.14
Volume4.75M
Market cap$1.30B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$304,000.00-19.6% YoY
Operating profit-$34.99M-16.1% YoY
Net profit-$33.30M-16.0% YoY
Diluted EPS-$0.19+5.0% YoY
Free cash flow-$29.48M-13.4% YoY
Operating cash flow-$29.47M

Revenue, last 8 quarters

$665.0KDec '24$1.2MMar '25$593.0KJun '25$378.0KSep '25$650.0KDec '25$215.0KMar '26$318.0KJun '26$304.0KSep '26

Net profit, last 8 quarters

$-29.0MDec '24$-26.3MMar '25$-30.6MJun '25$-28.7MSep '25$-29.6MDec '25$-29.6MMar '26$-33.2MJun '26$-33.3MSep '26

Diluted EPS by quarter

-0.25Dec '24-0.21Mar '25-0.24Jun '25-0.20Sep '25-0.20Dec '25-0.19Mar '26-0.21Jun '26-0.19Sep '26

Free cash flow by quarter

$-17.0MDec '24$-21.9MMar '25$-17.1MJun '25$-26.0MSep '25$-29.1MDec '25$-26.3MMar '26$-27.6MJun '26$-29.5MSep '26

Annual revenue

$4.8MFY20$4.8MFY21$5.7MFY22$5.7MFY23$4.5MFY24$2.8MFY25

Profitability & balance sheet

Operating margin-9,155.3%
Net margin-8,451.3%
Return on equity-58.6%
Return on assets-51.9%
Return on invested capital-57.3%
Current ratio9.64
Liabilities / assets8.7%
Cash & investments$173.73M
Total debt$1.20M
Net cash (debt)$172.53M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $304,000.00 $318,000.00 $215,000.00 $2.80M $650,000.00
Total Operating Revenue $304,000.00 $318,000.00 $215,000.00 $2.80M $650,000.00
Operating Expense $35.30M $34.48M $31.06M $128.22M $36.79M
Selling and Admin Expenses $9.04M $9.16M $9.06M $35.06M $8.62M
Research & Development $23.57M $22.62M $19.28M $81.42M $25.35M
Depreciation & Amortization & Depletion $2.69M $2.70M $2.73M $11.74M $2.83M
-Depreciation & Amortization $2.69M $2.70M $2.73M $11.74M $2.83M
Operating Profit -$34.99M -$34.16M -$30.85M -$125.42M -$36.14M
Net Non-Operating Interest Income (Expense) -$2,000.00 -$2,000.00 -$18,000.00 -$209,000.00 -$29,000.00
Non-Operating Interest Expense $2,000.00 $2,000.00 $18,000.00 $209,000.00 $29,000.00
Other Income (Expense) $1.71M $990,000.00 $1.28M $10.51M $6.45M
Other Non-Operating Income (Expenses) $1.71M $990,000.00 $1.28M $5.41M $1.35M
Pretax Profit -$33.28M -$33.17M -$29.58M -$115.11M -$29.72M
Tax $18,000.00 $40,000.00 $18,000.00 $69,000.00 -$162,000.00
Net Profit -$33.30M -$33.21M -$29.60M -$115.18M -$29.56M
Profit from Continuing Operations -$33.30M -$33.21M -$29.60M -$115.18M -$29.56M
Net Income to Parent Company -$33.30M -$33.21M -$29.60M -$115.18M -$29.56M
Net Income to Common Stockholders -$33.30M -$33.21M -$29.60M -$115.18M -$29.56M
Basic EPS -$0.19 -$0.21 -$0.19 -$0.84 -$0.20
Diluted EPS -$0.19 -$0.21 -$0.19 -$0.84 -$0.20
Special Income (Charges) – – – $5.10M –
-Less:Restructuring and Mergern & Acquisition – – – -$5.10M –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $239.57M $268.92M $195.59M $216.30M $216.30M
Total Current Assets $181.89M $208.27M $131.97M $149.57M $149.57M
Cash and Cash Equivalents & Short-Term Investments $173.73M $201.14M $125.71M $144.29M $144.29M
-Cash and Cash Equivalents $13.36M $107.87M $8.63M $20.03M $20.03M
-Short Term Investments $160.37M $93.28M $117.08M $124.27M $124.27M
Other Current Assets $8.16M $7.12M $6.27M $5.28M $5.28M
Total Non-Current Assets $57.68M $60.65M $63.62M $66.72M $66.72M
Net PPE $16.91M $19.16M $21.41M $23.77M $23.77M
-Gross PPE $16.91M $19.16M $21.41M $59.29M $59.29M
Goodwill and Other Intangible Assets $39.33M $40.05M $40.77M $41.51M $41.51M
-Other Intangible Assets $39.33M $40.05M $40.77M $41.51M $41.51M
Other Non-Current Assets $1.44M $1.44M $1.45M $1.44M $1.44M
Total Liabilities $20.90M $22.79M $23.62M $26.85M $26.85M
Total Current Liabilities $18.86M $19.60M $20.03M $22.77M $22.77M
Payables $6.01M $7.16M $8.83M $2.76M $2.76M
-Accounts Payable $6.01M $7.16M $8.83M $2.76M $2.76M
Current Accrued Expenses $9.62M $9.10M $8.49M $16.59M $16.59M
Short-Term Debt and Capital Lease Obligation $2.15M $2.19M $2.27M $2.68M $2.68M
-Current Debt $61,000.00 $150,000.00 $413,000.00 $873,000.00 $873,000.00
-Current Capital Lease Obligation $2.09M $2.04M $1.86M $1.81M $1.81M
Current Deferred Liabilities $1.09M $1.15M $450,000.00 $739,000.00 $739,000.00
Total Non-Current Liabilities $2.04M $3.19M $3.59M $4.08M $4.08M
Long Term Debt and Capital Lease Obligation $1.14M $1.64M $2.15M $2.62M $2.62M
-Long Term Capital Lease Obligation $1.14M $1.64M $2.15M $2.62M $2.62M
Non-Current Deferred Liabilities $0.00 $240,000.00 $641,000.00 $436,000.00 $436,000.00
Other Non-Current Liabilities $894,000.00 $1.31M $806,000.00 $1.02M $1.02M
Total Equity $218.68M $246.13M $171.97M $189.45M $189.45M
Stockholders' Equity $218.68M $246.13M $171.97M $189.45M $189.45M
Capital Stock $17,000.00 $17,000.00 $15,000.00 $15,000.00 $15,000.00
-Common Stock $17,000.00 $17,000.00 $15,000.00 $15,000.00 $15,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $940.07M $933.56M $826.04M $813.63M $813.63M
Retained Earnings -$720.89M -$687.59M -$654.38M -$624.78M -$624.78M
Gains/Losses Not Affecting Retained Earnings -$515,000.00 $150,000.00 $304,000.00 $591,000.00 $591,000.00
Restricted Cash – – – $0.00 $0.00
-Accumulated Depreciation – – – -$35.52M -$35.52M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$29.47M -$27.56M -$26.31M -$92.93M -$29.18M
Net cash flow from continuing operations -$29.47M -$27.56M -$26.31M -$92.93M -$29.18M
Net Income from Continuing Operations -$33.30M -$33.21M -$29.60M -$115.18M -$29.56M
Depreciation & Depletion & Amortization $2.69M $2.70M $2.73M $11.74M $2.83M
Other Non-Cash Items -$337,000.00 -$220,000.00 -$267,000.00 -$5.69M -$5.38M
Change in Working Capital -$2.13M -$1.74M -$3.13M $423,000.00 -$801,000.00
-Change in Receivables $0.00 $0.00 $0.00 $0.00 $1.00M
-Change in Prepaid Assets -$1.04M -$858,000.00 -$862,000.00 -$424,000.00 -$141,000.00
-Change in Payables and Accrued Expense -$631,000.00 -$1.05M -$2.04M $1.09M -$1.12M
-Change in Other Current Assets $0.00 $0.00 $0.00 $249,000.00 $0.00
-Change In Other Working Capital -$460,000.00 $166,000.00 -$226,000.00 -$496,000.00 -$544,000.00
Net cash flow from investing -$67.05M $24.07M $7.36M -$50.16M $19.55M
Net Cash Flow from Continuing Investing Activities -$67.05M $24.07M $7.36M -$50.16M $19.55M
Net PPE Purchase and Sale -$9,000.00 $41,000.00 -$26,000.00 $205,000.00 $232,000.00
Net Investment Purchase and Sale -$67.04M $24.03M $7.39M -$50.37M $19.32M
Financing Cash Flow $2.02M $102.73M $7.56M $105.95M $3.84M
Net Cash Flow from Continuing Financing Activities $2.02M $102.73M $7.56M $105.95M $3.84M
Net Issuance Payments Of Debt -$89,000.00 -$263,000.00 -$460,000.00 -$3.20M -$500,000.00
Net Common Stock Issuance $0.00 $98.14M $7.96M $105.84M $3.50M
Proceeds from Stock Option Exercised $2.11M $4.85M $59,000.00 $3.31M $843,000.00
Ending Cash Balance $14.42M $108.92M $9.69M $21.08M $21.08M
Net Change in Cash -$94.50M $99.23M -$11.39M -$37.14M -$5.79M
Beginning Cash Balance $108.92M $9.69M $21.08M $58.21M $26.87M
Free Cash Flow -$29.48M -$27.57M -$26.34M -$94.03M -$29.08M

Discussion

No comments yet — be the first to weigh in on ABSI.

Sign in to join the discussion.

Scroll to Top